The main cause of COPD in developed countries is tobacco smoking. In the developing world, COPD often occurs in people exposed to fumes from burning fuel for cooking and heating in poorly ventilated homes.
Only about 25 percent of chronic smokers develop clinically apparent COPD, although up to half have subtle evidence of COPD. Some smokers develop less common lung conditions. They may be misdiagnosed as having COPD until a more thorough evaluation is performed.
How your lungs are affected
Air travels down your windpipe (trachea) and into your lungs through two large tubes (bronchi). Inside your lungs, these tubes divide many times — like the branches of a tree — into many smaller tubes (bronchioles) that end in clusters of tiny air sacs (alveoli). The air sacs have very thin walls full of tiny blood vessels (capillaries). The oxygen in the air you inhale passes into these blood vessels and enters your bloodstream. At the same time, carbon dioxide — a gas that is a waste product of metabolism — is exhaled.
Your lungs rely on the natural elasticity of the bronchial tubes and air sacs to force air out of your body. COPD causes them to lose their elasticity and overexpand, which leaves some air trapped in your lungs when you exhale.
Causes of airway obstruction
- Emphysema. This lung disease causes destruction of the fragile walls and elastic fibers of the alveoli. Small airways collapse when you exhale, impairing airflow out of your lungs.
- Chronic bronchitis. In this condition, your bronchial tubes become inflamed and narrowed and your lungs produce more mucus, which can further block the narrowed tubes. You develop a chronic cough trying to clear your airways.
Cigarette smoke and other irritants
In the vast majority of cases, the lung damage that leads to COPD is caused by long-term cigarette smoking. But there are likely other factors at play in the development of COPD, such as a genetic susceptibility to the disease, because only about 25 percent of smokers develop COPD.
Other irritants can cause COPD, including cigar smoke, secondhand smoke, pipe smoke, air pollution and workplace exposure to dust, smoke or fumes.
In about 1 percent of people with COPD, the disease results from a genetic disorder that causes low levels of a protein called alpha-1 antitrypsin. Alpha-1-antitrypsin (AAt) is made in the liver and secreted into the bloodstream to help protect the lungs. Alpha-1-antitrypsin deficiency can affect the liver as well as the lungs. Damage to the liver can occur in infants and children, not just adults with long smoking histories.
For adults with COPD related to AAt deficiency, treatment options include those used for people with more common types of COPD. In addition, some people can be treated by replacing the missing AAt protein, which may prevent further damage to the lungs.
July 21, 2015
- Balkissoon R, et al. Chronic obstructive pulmonary disease: A concise review. Medical Clinics of North America. 2011;95:1125.
- Longo DL, et al. Chronic obstructive pulmonary disease (COPD). Harrison's Online. 18th ed. New York, N.Y.: The McGraw-Hill Companies; 2012. http://www.accessmedicine.com. Accessed June 3, 2015.
- What is COPD? National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/copd/. Accessed June 3, 2015.
- Standards for the diagnosis and management of patients with COPD. American Thoracic Society. http://www.thoracic.org/clinical/copd-guidelines/index.php. Accessed June 4, 2015.
- Hanley ME, et al. Chronic obstructive pulmonary disease. In: Current Diagnosis & Treatment in Pulmonary Medicine. New York, N.Y.: The McGraw-Hill Companies; 2003. http://accessmedicine.mhmedical.com/content.aspx?bookid=346§ionid=39883254. Accessed June 4, 2015.
- Foreman MG. Genes and chronic obstructive pulmonary disease. Medical Clinics of North America. 2012;96:699.
- Rosenberg SR, et al. An integrated approach to the medical treatment of chronic obstructive pulmonary disease. Medical Clinics of North America. 2012;96:811.
- AskMayoExpert. Chronic pulmonary obstructive disease. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
- Scanlon PD (expert opinion). Mayo Clinic, Rochester, Minn. June 4, 2015.